JACQUALYN A FOUSE
CIK 1405288 · Chief Executive Officer · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.84M
Companies
8
Total Filings
139
Lifetime Open-Market Net
$590.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AGIO | Director | 154,156 | $35.99 | $5.55M | $112.3K | 24 | 2026-06-23 |
| MDGL | Director | 1,551 | $538.80 | $835.7K | $0 | 3 | 2026-06-18 |
| INCY | Director | 20,968 | $129.93 | $2.72M | $0 | 30 | 2026-06-10 |
| DKS | Director | 55,288 | $211.37 | $11.69M | $0 | 11 | 2020-03-24 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | 85,840 | — | — | $478.2K | 42 | 2017-02-16 |
| PRGO | Director | 4,360 | $10.30 | $44.9K | $0 | 8 | 2016-05-06 |
| CELGENE CORP /DE/ (CELG) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2010-10-14 |
| BG | Chief Financial Officer | 0 | $117.37 | $0 | $0 | 18 | 2010-09-07 |
Recent Filings · Page 3 of 14
139 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-04 | INCY | Grant (A) | +252 | $20.2K | EDGAR |
| 2022-10-04 | INCY | Grant (A) | +291 | $19.4K | EDGAR |
| 2022-07-01 | INCY | Grant (A) | +275 | $20.9K | EDGAR |
| 2022-06-17 | INCY | Grant (A) | +2,144 | $0 | EDGAR |
| 2022-04-12 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | INCY | Grant (A) | +280 | $22.2K | EDGAR |
| 2022-02-23 | AGIO | Mixed | +8,705 | -$106.8K | EDGAR |
| 2022-02-16 | AGIO | Mixed | +7,829 | -$106.9K | EDGAR |
| 2022-01-04 | INCY | Grant (A) | +289 | $21.2K | EDGAR |
| 2021-10-04 | INCY | Grant (A) | +271 | $18.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.